References
  1. Callaghan, WM., Kuklina, EV., Berg, CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol 2010;202:353.e1–6
  2. Ngwenya S. Postpartum hemorrhage: incidence, risk factors, and outcomes in a low-resource setting. Int J Womens Health. 2016;8:647–650. Published 2016 Nov 2.
  3. Klebanoff, J., Marfori, C., Ingraham, C., Wu, C., & Moawad, G. (2019). Applications of Tranexamic acid in benign gynecology. Current opinion in obstetrics & gynecology
  4. Dunn C.J., Goa K.L. Tranexamic acid. Drugs. 1999;57(6):1005–1032. http://link.springer.com/10.2165/00003495-199957060-00017
  5. Roberts I, Shakur H, Coats T, Hunt B, Balogun E, Barnetson L, et al. The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients. Health Technol Assess. 2013;17(10):1–79. doi: 10.3310/hta17100.
  6. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs 2012; 72:585–617
  7. Panteli, M., Pountos, I., & Giannoudis, P. V. (2016). Pharmacological adjuncts to stop bleeding: options and effectiveness. European journal of trauma and emergency surgery : official publication of the European Trauma Society, 42(3), 303–310. doi:10.1007/s00068-015-0613-x
  8. WOMAN Trial Collaborators. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial [published correction appears in Lancet. 2017 May 27;389(10084):2104]. Lancet. 2017;389(10084):2105–2116. doi:10.1016/S0140-6736(17)30638-4
  9. WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage.World Health Organization, Geneva2017
  10. (Barber EL, Lundsberg LS, Belanger K, Pettker CM, Funai EF, Illuzzi JL. Indications contributing to the increasing cesarean delivery rate. Obstet Gynecol. 2011;118(1):29–38. doi:10.1097/AOG.0b013e31821e5f65
  11. Healy TE, Knight PR. Obstetric Anaesthesia. Wylie and Churchill-Davidson’s A Practice of Anaesthesia. 7 th ed. London: Arnold; 2003
  12. Ekeroma AJ, Ansari A, Stirrat GM. Blood transfusion in obstetrics and gynaecology. Br J Obstet Gynaecol 1997;104:278-84
  13. Retrieved from https://www.cdc.gov/nchs/fastats/delivery.htm January 20, 2017Content source: CDC/National Center for Health Statistics
  14. Gai MY, Wu LF, Su QF, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: A multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 2004;112:154-7.
  15. Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti AD. Efficacy of tranexamic acid in reducing blood loss after cesarean section. J Matern Fetal Neonatal Med 2009;22:72-5.
  16. Gohel M, Patel P, Gupta A, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: A randomized case controlled prospective study. Obstet Gynaecol India 2007;57:227-30.
  17. Callender, S. T., Warner, G. T., & Cope, E. (1970). Treatment of menorrhagia with tranexamic acid. A double-blind trial. British medical journal, 4(5729), 214–216. doi:10.1136/bmj.4.5729.2
  18. Lukes, A., Freeman, E., Van Drie, D., Baker, J., Adomako, T. Safety of tranexamic acid in women with heavy menstrual bleeding: an open-label extension study. Womens Health (Lond) 2011 Sep; 7(5): 591–598. doi: 10.2217/whe.11.55).
  19. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol. 2007;110:1091–5.
  20. Topsoee, M., Settnes, A., Ottesen, B., Bergholt, T. A systematic review and meta-analysis of the effect of prophylactic tranexamic acid treatment in major benign uterine surgery. Int J Gynaecol Obstet. 2017 Feb; 136(2): 120–127. Published online 2016 Dec 9. doi: 10.1002/ijgo.12047
  21. Shaaban, M. M., Ahmed, M. R., Farhan, R. E., & Dardeer, H. H. (2016). Efficacy of Tranexamic Acid on Myomectomy-Associated Blood Loss in Patients With Multiple Myomas: A Randomized Controlled Clinical Trial. Reproductive Sciences, 23(7), 908–912.
  22. Topsoee MF, Bergholt T, Ravn P, et al. Anti-hemorrhagic effect of prophylactic tranexamic acid in benign hysterectomy-a double-blinded randomized placebo-controlled trial. American Journal of Obstetrics and Gynecology. 2016 Jul;215(1):72.e1-8. DOI: 10.1016/j.ajog.2016.01.184.
  23. Retrieved on April 16, 2020 from http://www.caog.org/. Central Association of Obstetricians and Gynecologists.